About this trial
Projecte Benestar 2026 is a multicenter randomized controlled study evaluating a brief immersive educational program delivered through virtual reality for healthcare workers. The program is designed to support emotional well-being, self-care, mindfulness, and emotional regulation in professionals working in healthcare settings.
Participants will be active healthcare or healthcare-support workers from participating centers. They will be randomly assigned to one of two groups. One group will receive the virtual reality program at the beginning of the study, while the other group will continue usual activity and receive the same program later, after a wait-list period.
The main objective is to evaluate whether the program reduces emotional exhaustion, measured with the Maslach Burnout Inventory. Secondary objectives include evaluating changes in depersonalization, personal accomplishment, work engagement, usability, satisfaction, adherence, and tolerability of the virtual reality program.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Active permanent or temporary staff member at a participating healthcare center where the program is implemented
Age 18 years or older
Able to understand, accept, and sign the informed consent form
Willing to complete the study procedures, attend the planned weekly sessions, and complete the study questionnaires
Disqualifiers
Photosensitive epilepsy or history of seizures triggered by visual stimuli
Severe motion sickness or previous intolerance to immersive devices
Visual or hearing impairment that prevents adequate use of the virtual reality headset
Trial design
Parallel
Treatments tested in this trial
Projecte Benestar Virtual Reality Educational Program
BehavioralProjecte Benestar is an immersive educational virtual reality program focused on mindfulness, emotional regulation, and self-compassion for workers in healthcare settings. The program includes 8 individual sessions delivered through autonomous virtual reality headsets. Each session lasts approximately 9 to 15 minutes and includes guided audio and immersive 3D content. Sessions may be delivered over 8 weeks or in an intensive 4-week format, depending on local logistics.
Treatment groups
Trial outcomes
Primary outcomes
Change in Emotional Exhaustion Score on the Maslach Burnout Inventory-Human Services Survey
Emotional exhaustion will be assessed using the Emotional Exhaustion subscale of the Maslach Burnout Inventory-Human Services Survey. The subscale includes 9 items scored from 0 to 6, with total scores ranging from 0 to 54. Higher scores indicate greater emotional exhaustion. Changes will be compared between the immediate intervention group and the wait-list control group during the first intervention period, and will also be assessed after the delayed intervention group completes the program.
Secondary outcomes
Change in Depersonalization Score on the Maslach Burnout Inventory-Human Services Survey
Depersonalization will be assessed using the Depersonalization subscale of the Maslach Burnout Inventory-Human Services Survey. The subscale includes 5 items scored from 0 to 6, with total scores ranging from 0 to 30. Higher scores indicate greater depersonalization.
Change in Personal Accomplishment Score on the Maslach Burnout Inventory-Human Services Survey
Personal accomplishment will be assessed using the Personal Accomplishment subscale of the Maslach Burnout Inventory-Human Services Survey. The subscale includes 8 items scored from 0 to 6, with total scores ranging from 0 to 48. Higher scores indicate greater personal accomplishment.
Change in Vigor Score on the Utrecht Work Engagement Scale-9
Vigor will be assessed using the Vigor dimension of the Utrecht Work Engagement Scale-9. This dimension includes 3 items scored from 0 to 6. The dimension score will be calculated as the mean of the items, ranging from 0 to 6. Higher scores indicate greater vigor, reflecting higher energy and mental resilience at work.
Change in Dedication Score on the Utrecht Work Engagement Scale-9
Dedication will be assessed using the Dedication dimension of the Utrecht Work Engagement Scale-9. This dimension includes 3 items scored from 0 to 6. The dimension score will be calculated as the mean of the items, ranging from 0 to 6. Higher scores indicate greater dedication, reflecting a stronger sense of significance, enthusiasm, inspiration, pride, and challenge at work.
Other outcomes
Tolerability of the Virtual Reality Program
Tolerability will be assessed immediately after Sessions 1 through 8 and at intervention completion by recording symptoms related to virtual reality use, including eye fatigue, blurred vision, headache, dizziness, nausea, disorientation, anxiety, or ergonomic discomfort. Symptoms will be rated using an ad hoc 4-point scale from none to severe. Lower scores indicate better tolerability.
Incidence of Virtual Reality-Related Adverse Events or Session Interruptions
Virtual reality-related incidents will be recorded after each session using a session incident log. Events may include dizziness, cybersickness, headache, anxiety, visual discomfort, or other symptoms leading to session interruption or withdrawal. The outcome will be summarized as the number and proportion of participants with any recorded incident.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Badalona Serveis Assistencials
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Collaborator
Corporació de Salut del Maresme i la Selva
Collaborator
Institut Catala de Salut
Collaborator